Biotechnology Stocks I Performance Guide: Spyre Therapeutics, Inc. (SYRE)
SYRE has no dividends.
Table and Chart of SYRE Performance
See what a $1,000 investment in SYRE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SYRE Returns | |
|---|---|
| Start Date | May-31-2016 |
| Start Price | $187.50 |
| End Date | May-07-2024 |
| End Price | $34.24 |
| # Prices | 97 |
| Min Date | May-31-2023 |
| Min Price | $3.25 |
| Max Date | Aug-31-2018 |
| Max Price | $273.25 |
| Total Return | -81.74% |
| Annualized Return | -18.97% |
| Current Value of $1,000 Purchase | $183 |
| Number Returns | 4,656 |
| Average Return | -22.16% |
| Number Profitable Returns | 1,522 |
| Percent Profitable Returns | 32.69% |
| Number Unprofitable Returns | 3,134 |
| Percent Unprofitable Returns | 67.31% |
| Profitable to Unprofitable Returns Ratio | 0.49 |
| SYRE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $990,577,000 |
| Beta | 2.850 | Price to Sales | 939.83 |
| Earnings per Share | $0.0000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $47.97 |
| 52 Week Low | $2.65 |
| Analyst Target Price | $30.33 |
| 50-Day Moving Average | $18.7 |
| 200-Day Moving Average | $11.9 |
| FINANCIAL DATA | |
| Revenue per Share | $0.269 |
| Revenue | $1,054,000 |
| Profit Margin | 0% |
| Return on Equity | -281.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SYRE Compare Returns with S&P 500
SYRE Trendline Chart
SYRE Moving Average Chart
SYRE Stock Return Map - See Patterns of Gains and Losses
SYRE Stock Returns/Purchase Dates